It is possible that, owing to the lack of the surface targeting FH18-20 domains, administration of fusion proteins containing FH1-5 in FH deficiency could result in susceptibility to thrombotic microangiopathy. This evidence concerns the gene FLNB and Genetic thrombotic microangiopathy.